Repro Med Systems Inc Total Liabilities
Repro Med Systems Inc total liabilities. Based on the latest financial reports, Repro Med Systems Inc (KRMD) has total liabilities worth $9.91 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Repro Med Systems Inc (KRMD) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Repro Med Systems Inc (1996–2025)
Total liabilities of Repro Med Systems Inc from 1996 to 2025. This chart illustrates how Repro Med Systems Inc's total liabilities have evolved over time, based on quarterly financial data.
Repro Med Systems Inc Competitors by Total Liabilities
The table below lists competitors of Repro Med Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UPDATER SERVICES LIMITED
NSE:UDS
|
India | Rs5.84 Billion |
|
Uttam Sugar Mills Limited
NSE:UTTAMSUGAR
|
India | Rs10.48 Billion |
|
Clarus Corp
NASDAQ:CLAR
|
USA | $56.76 Million |
|
Protara Therapeutics Inc
NASDAQ:TARA
|
USA | $14.78 Million |
|
1911 Gold Corp
V:AUMB
|
Canada | CA$35.65 Million |
|
Gs Global
KO:001250
|
Korea | ₩1.10 Trillion |
|
K2 Capital Acquisition Corporation
NASDAQ:KTWO
|
USA | $272.00K |
|
ABC Taiwan Electronics
TWO:3236
|
Taiwan | NT$1.50 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Repro Med Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Repro Med Systems Inc assets under control.
Liquidity & Leverage Metrics
Repro Med Systems Inc Total Liabilities Ratios Explained
Repro Med Systems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Repro Med Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Repro Med Systems Inc (1996–2025)
The table below shows the annual total liabilities of Repro Med Systems Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $11.15 Million | +7.18% |
| 2024-12-31 | $10.40 Million | +28.34% |
| 2023-12-31 | $8.11 Million | -26.34% |
| 2022-12-31 | $11.01 Million | +129.69% |
| 2021-12-31 | $4.79 Million | +27.38% |
| 2020-12-31 | $3.76 Million | +42.19% |
| 2019-12-31 | $2.65 Million | +67.01% |
| 2018-12-31 | $1.58 Million | -1.67% |
| 2017-12-31 | $1.61 Million | +7.83% |
| 2016-12-31 | $1.49 Million | +5.03% |
| 2015-12-31 | $1.42 Million | +41.18% |
| 2014-12-31 | $1.01 Million | -0.90% |
| 2013-12-31 | $1.02 Million | -17.71% |
| 2012-12-31 | $1.24 Million | -1.50% |
| 2011-12-31 | $1.25 Million | +31.13% |
| 2010-12-31 | $956.63K | -29.51% |
| 2009-12-31 | $1.36 Million | -15.47% |
| 2008-12-31 | $1.61 Million | -9.93% |
| 2007-12-31 | $1.78 Million | -0.11% |
| 2006-12-31 | $1.78 Million | +20.01% |
| 2005-12-31 | $1.49 Million | +6.72% |
| 2004-12-31 | $1.39 Million | +2.31% |
| 2003-12-31 | $1.36 Million | +29.75% |
| 2002-12-31 | $1.05 Million | -1.17% |
| 2001-12-31 | $1.06 Million | +41.76% |
| 2000-12-31 | $749.03K | -18.29% |
| 1999-12-31 | $916.66K | -48.50% |
| 1998-12-31 | $1.78 Million | -17.59% |
| 1997-12-31 | $2.16 Million | +83.05% |
| 1996-12-31 | $1.18 Million | -- |
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropath… Read more